Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 30 of 35 / 832 articles
After 100 deep dives into every corner of the nicotine landscape, a few truths have emerged—not about the science (though that too), but about the human dimensions of addiction, policy, and the search for a better way.
The vaping debate is trapped in a false binary: is vaping safe or dangerous? The question that actually matters is: compared to what, for whom, under what conditions? Until we start asking better questions, we'll keep getting worse answers.
This one isn't for the policymakers, the researchers, or the advocates. It's for you—the person holding a cigarette right now, wanting to stop, not knowing if you can. You're not weak. You're fighting one of the hardest battles in medicine. And there's hope.
Smoking is often described as a regressive tax on the poor. It's worse than that—it's a regressive industry that extracts wealth from the most vulnerable, transfers it to shareholders, and returns disease.
LGBTQ+ people smoke at nearly twice the rate of the general population—a legacy of targeted industry marketing, minority stress, and healthcare disparities. Can harm reduction reach a community that public health has often failed?
Getting from 20 cigarettes a day to 2 is hard. Getting from 2 to zero is harder—and the neuroscience explains why. The smokers who've cut down but can't quit are not weak. They're fighting a different battle than the one they started.
Both the tobacco industry and some tobacco control advocates distort the evidence on nicotine. Here's a field guide to the most common myths, the kernels of truth that sustain them, and how to evaluate nicotine claims critically.
Cigarette smoke doesn't just damage lungs—it accelerates the metabolism of many psychiatric medications, making them less effective. When smokers quit, their medication levels can rise dramatically. The clinical implications are profound.
Nicotine pouches have been around for years in Sweden. But in 2025, they crossed a threshold: from niche Scandinavian product to global mass-market phenomenon. The numbers are staggering, and the implications are profound.
The Wild West era of vaping—thousands of brands, minimal regulation, explosive growth—is ending. What's emerging is a consolidated, regulated, and increasingly corporate industry. Who survives, and what's lost?
What will the nicotine landscape look like in 2035? Based on current trends, here are ten evidence-grounded predictions—some hopeful, some alarming, all uncertain.
MPOWER measures—monitoring, smoke-free laws, cessation, warnings, ad bans, taxation—have driven smoking down dramatically. But the decline is slowing, and the remaining smokers are the hardest to reach. What comes next?
Vapers have organized—online, at the ballot box, and in the streets—to defend their access to the products they credit with saving their lives. The movement is passionate, politically diverse, and increasingly effective.
Pharmacists are the most accessible healthcare professionals in most communities, and they're uniquely positioned to deliver smoking cessation support. Why aren't we using them?
Nicotine pouches, gums, lozenges, toothpicks, and dissolving tablets—the oral nicotine category is exploding into micro-formats, each with its own user base, use case, and regulatory gray area.
The evidence for tobacco harm reduction is stronger than ever. So why does the public health establishment remain opposed? The answer lies in institutional culture, funding structures, and the psychology of expertise.
For decades, particularly among women, cigarettes have been used as a weight management tool. Understanding this connection—and offering alternatives that don't kill—is one of the most neglected aspects of smoking cessation.
If regulators ban nicotine, chemists will make something that looks like nicotine, acts like nicotine, but isn't legally 'nicotine.' The analogue pipeline is already flowing, and the regulatory system isn't ready.
Vape shop staff aren't doctors. They're not trained in addiction medicine. But every day, they guide smokers through the most important health decision of their lives. The system is improvised, unregulated, and surprisingly effective.
Indigenous peoples smoke at rates far exceeding settler populations—a direct legacy of colonial trade, displacement, and targeted marketing. Addressing this gap requires confronting history, not just promoting cessation.
Nicotine withdrawal is uncomfortable, distracting, and demoralizing—but it's also predictable, time-limited, and manageable with the right strategies. Here's what the neuroscience says about navigating the hardest part of quitting.
Japan didn't embrace vaping—nicotine e-liquid is effectively banned. Instead, it embraced heated tobacco. The Japanese experience challenges every assumption in the global nicotine debate.
Smokers take more breaks, earn less, and face increasing workplace discrimination. The smoking break is a microcosm of how nicotine addiction intersects with class, productivity, and fairness in the modern workplace.
For years, nicotine regulation hinged on a single word: 'tobacco.' When chemists figured out how to synthesize nicotine without tobacco plants, the entire regulatory framework was thrown into question.
Products
Select a product to view details, highlights, and technical specifications.
